Libra Therapeutics is focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases.
Location: United States, California, San Diego
Total raised: $29M
Investors 2
Date | Name | Website |
06.12.2020 | Dolby Fami... | dolbyventu... |
- | Epidarex C... | epidarex.c... |
Funding Rounds 1
Date | Series | Amount | Investors |
29.09.2020 | Series A | $29M | - |
Mentions in press and media 6
Date | Title | Description | Source |
29.09.2020 | Libra Therapeutics Raises $29M | Libra Therapeutics, a biotechnology company focused on developing novel disease-modifying therapeuti... | sdbj.com/n... |
23.09.2020 | Libra Therapeutics Launches with $29M Series A | SAN DIEGO, CA, Libra Therapeutics has secured $29 million in Series A financing co-led by Boehring... | vcnewsdail... |
23.09.2020 | Libra Therapeutics Launches with $29 Million Series A | SAN DIEGO--(BUSINESS WIRE)--Libra Therapeutics, Inc. launched today to develop novel drug candidates... | citybizlis... |
23.09.2020 | Libra Therapeutics Nabs $29M For Neurodegenerative Disea... | San Diego-based Libra Therapeutics, a new startup developing treatments for various neurodegenerativ... | socaltech.... |
23.09.2020 | Libra Therapeutics Raises $29M in Series A Funding | Libra Therapeutics, Inc., a San Diego, CA-based developer of novel drug candidates focused on restor... | finsmes.co... |
23.09.2020 | Libra Therapeutics has raised a $29M Series A round to devel... | - | connect.or... |